1,316.43 million, up from the same period of the previous year by Baht 473.27 million mainly due to increased share of profit from associated companies as Bangkok Expressway and Metro Public Company Limited
of 2020 was Baht 1,828 million, decrease by Baht 38 million or -2.0% from the same quarter of last year and decrease by Baht 440 million or -19.4% from the previous quarter. Sales declined from the
% Change Amount % Amount % Amount % Q1-20 VS Q1-19 Q1-20 VS Q4-19 Sales revenue 12,680 100.0 12,949 100.0 11,707 100 (2.1) 8.3 Gross profit 2,586 20.4 2,978 23.0 2,155 18.4 (13.2) 20.0 Operating profit 549
results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
by the auditor . The results of operations are as follows . The Company's performance For nine months As of September 30, 2017, the net profit (loss) was Baht 22.57 million, compared with the same
increased by THB 29.8 mm or 2.8%, compared to the same period of the last year. If excluding FX impact, the normalized net profit increased by THB 312.1 mm or 38.3%. If considering only 3-month period ending
the payment of such shares shall be by means of share swap. The acquisition of shares in S-TREK is divided into 2 parts sold at the same price of approximately Baht 33.33 per share as follows: Part 1
quarter of 2019, the Company had the net profit of THB 1,051.9 and 1,458.5 mm, which increased by 748.9 and THB 375.6 mm or 247.1% and 34.7%,respectively, compared to the same period of the last year. KEY
% for the warehouse rental and service business which decreased from 57.0% in the same period of previous year, mainly due to change in product mix between Built-to-Suit and Ready- built facilities. 2